<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28213398</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1479-6805</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>233</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of endocrinology</Title>
          <ISOAbbreviation>J Endocrinol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>FoxO integration of insulin signaling with glucose and lipid metabolism.</ArticleTitle>
        <Pagination>
          <StartPage>R67</StartPage>
          <EndPage>R79</EndPage>
          <MedlinePgn>R67-R79</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1530/JOE-17-0002</ELocationID>
        <Abstract>
          <AbstractText>The forkhead box O family consists of FoxO1, FoxO3, FoxO4 and FoxO6 proteins in mammals. Expressed ubiquitously in the body, the four FoxO isoforms share in common the amino DNA-binding domain, known as 'forkhead box' domain. They mediate the inhibitory action of insulin or insulin-like growth factor on key functions involved in cell metabolism, growth, differentiation, oxidative stress, senescence, autophagy and aging. Genetic mutations in FoxO genes or abnormal expression of FoxO proteins are associated with metabolic disease, cancer or altered lifespan in humans and animals. Of the FoxO family, FoxO6 is the least characterized member and is shown to play pivotal roles in the liver, skeletal muscle and brain. Altered FoxO6 expression is associated with the pathogenesis of insulin resistance, dietary obesity and type 2 diabetes and risk of neurodegeneration disease. FoxO6 is evolutionally divergent from other FoxO isoforms. FoxO6 mediates insulin action on target genes in a mechanism that is fundamentally different from other FoxO members. Here, we focus our review on the role of FoxO6, in contrast with other FoxO isoforms, in health and disease. We review the distinctive mechanism by which FoxO6 integrates insulin signaling to hepatic glucose and lipid metabolism. We highlight the importance of FoxO6 dysregulation in the dual pathogenesis of fasting hyperglycemia and hyperlipidemia in diabetes. We review the role of FoxO6 in memory consolidation and its contribution to neurodegeneration disease and aging. We discuss the potential therapeutic option of pharmacological FoxO6 inhibition for improving glucose and lipid metabolism in diabetes.</AbstractText>
          <CopyrightInformation>© 2017 Society for Endocrinology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Sojin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology and DiabetesDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>H Henry</ForeName>
            <Initials>HH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology and DiabetesDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA dongh@pitt.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DK098437</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>02</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Endocrinol</MedlineTA>
        <NlmUniqueID>0375363</NlmUniqueID>
        <ISSNLinking>0022-0795</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">FoxO1</Keyword>
        <Keyword MajorTopicYN="Y">FoxO3</Keyword>
        <Keyword MajorTopicYN="Y">FoxO4</Keyword>
        <Keyword MajorTopicYN="Y">FoxO6</Keyword>
        <Keyword MajorTopicYN="Y">diabetes</Keyword>
        <Keyword MajorTopicYN="Y">glucose metabolism</Keyword>
        <Keyword MajorTopicYN="Y">insulin signaling</Keyword>
        <Keyword MajorTopicYN="Y">lipid metabolism</Keyword>
        <Keyword MajorTopicYN="Y">obesity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28213398</ArticleId>
        <ArticleId IdType="mid">NIHMS857969</ArticleId>
        <ArticleId IdType="pmc">PMC5480241</ArticleId>
        <ArticleId IdType="doi">10.1530/JOE-17-0002</ArticleId>
        <ArticleId IdType="pii">JOE-17-0002</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117:421–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15137936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol. 1990;258:E1020–1032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2193527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, Dong HH. Foxo1 Mediates Insulin Action on ApoC-III and Triglyceride Metabolism. J Clin Invest. 2004;114:1493–1503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC525736</ArticleId>
            <ArticleId IdType="pubmed">15546000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, Condorelli G, Bellazzi R, Puca AA. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009;12:95–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19415983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab. 2005;16:183–189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15860415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brent MM, Anand R, Marmorstein R. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure. 2008;16:1407–1416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2597217</ArticleId>
            <ArticleId IdType="pubmed">18786403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calabuig-Navarro V, Yamauchi J, Lee S, Zhang T, Liu YZ, Sadlek K, Coudriet GM, Piganelli JD, Jiang CL, Miller R, et al.  Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. J Biol Chem. 2015;290:15581–15594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4505471</ArticleId>
            <ArticleId IdType="pubmed">25944898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;301:215–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12855809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherrington AD. The role of hepatic insulin receptors in the regulation of glucose production. J Clin Invest. 2005;115:1136–1139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1087191</ArticleId>
            <ArticleId IdType="pubmed">15864342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba T, Kamei Y, Shimizu T, Shirasawa T, Katsumata A, Shiraishi L, Sugita S, Ogawa Y, Miura S, Ezaki O. Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice. Mech Ageing Dev. 2009;130:420–428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19426753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab. 2011;22:353–363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3163828</ArticleId>
            <ArticleId IdType="pubmed">21616678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung SY, Huang WC, Su CW, Lee KW, Chi HC, Lin CT, Chen ST, Huang KM, Tsai MS, Yu HP, et al.  FoxO6 and PGC-1alpha form a regulatory loop in myogenic cells. Biosci Rep. 2013;33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3681252</ArticleId>
            <ArticleId IdType="pubmed">23639108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cifarelli V, Lee S, Kim DH, Zhang T, Kamagate A, Slusher S, Bertera S, Luppi P, Trucco M, Dong HH. FOXO1 Mediates the Autocrine Effect of Endothelin-1 on Endothelial Cell Survival. Mol Endocrinol. 2012;26:1213–1224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3385789</ArticleId>
            <ArticleId IdType="pubmed">22570335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobson AJ, Ezcurra M, Flanagan CE, Summerfield AC, Piper MD, Gems D, Alic N. Nutritional Programming of Lifespan by FOXO Inhibition on Sugar-Rich Diets. Cell Rep. 2017;18:299–306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5263231</ArticleId>
            <ArticleId IdType="pubmed">28076775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong X, Biswas A, Suel KE, Jackson LK, Martinez R, Gu H, Chook YM. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature. 2009;458:1136–1141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3437623</ArticleId>
            <ArticleId IdType="pubmed">19339969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgerton DS, Johnson KM, Cherrington AD. Current strategies for the inhibition of hepatic glucose production in type 2 diabetes. Front Biosci. 2009;14:1169–1181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19273123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekberg K, Landau BR, Wajngot A, Chandramouli V, Efendic S, Brunerngraber H, Wahren J. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999;48:292–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10334304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 2005;308:1181–1184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15905404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. Embo J. 2004;23:4802–4812.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC535088</ArticleId>
            <ArticleId IdType="pubmed">15538382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S, Schreiber S, Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A. 2009;106:2700–2705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2650329</ArticleId>
            <ArticleId IdType="pubmed">19196970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuyama T, Kitayama K, Shimoda Y, Ogawa M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S, Nakayama K, Ikeda K, et al.  Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem. 2004;279:34741–34749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15184386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuyama T, Nakazawa T, Nakano I, Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J. 2000;349:629–634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1221187</ArticleId>
            <ArticleId IdType="pubmed">10880363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giannakou ME, Goss M, Junger MA, Hafen E, Leevers SJ, Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science. 2004;305:361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15192154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giannakou ME, Goss M, Partridge L. Role of dFOXO in lifespan extension by dietary restriction in Drosophila melanogaster: not required, but its activity modulates the response. Aging Cell. 2008;7:187–198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18241326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon DA, Wetterau JR, Gregg RE. Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles. Trends Cell Biol. 1995;5:317–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14732096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 1998;17:2224–2234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1170567</ArticleId>
            <ArticleId IdType="pubmed">9545236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haeusler RA, Kaestner KH, Accili D. FoxOs function synergistically to promote glucose production. J Biol Chem. 2010;285:35245–35248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2975147</ArticleId>
            <ArticleId IdType="pubmed">20880840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoekman MF, Jacobs FM, Smidt MP, Burbach JP. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr Patterns. 2006;6:134–140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16326148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holm C, Osterlund T, Laurell H, Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr. 2000;20:365–393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10940339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosaka T, Biggs WH, 3rd, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004;101:2975–2980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC365730</ArticleId>
            <ArticleId IdType="pubmed">14978268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui TY, Olivier LM, Kang S, Davis RA. Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride. J Lipid Res. 2002;43:785–793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11971950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res. 2003;44:22–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12518019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004;429:562–566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15175753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>OS I, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, DePinho RA, Stolz DB, Kahn CR, Schwartz MW, et al.  FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun. 2015;6:7079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4755301</ArticleId>
            <ArticleId IdType="pubmed">25963540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol. 2003;5:330–335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12640462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF, Smidt MP. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem. 2003;278:35959–35967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12857750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang H, Lee GY, Selby CP, Lee G, Jeon YG, Lee JH, Cheng KK, Titchenell P, Birnbaum MJ, Xu A, et al.  SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding. Nat Commun. 2016;7:12180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4947181</ArticleId>
            <ArticleId IdType="pubmed">27412556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284:E671–678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12626323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamagate A, Dong HH. FoxO1 integrates insulin signaling to VLDL production. Cell Cycle. 2008;7:3162–3170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2664837</ArticleId>
            <ArticleId IdType="pubmed">18927507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest. 2008;118:2347–2364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2391277</ArticleId>
            <ArticleId IdType="pubmed">18497885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karim MA, Craig RL, Wang X, Hale TC, Elbein SC. Analysis of FOXO1A as a candidate gene for type 2 diabetes. Mol Genet Metab. 2006;88:171–177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16497530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato S, Ding J, Pisck E, Jhala US, Du K. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 2008;283:35464–35473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2602905</ArticleId>
            <ArticleId IdType="pubmed">18815134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kibbe C, Chen J, Xu G, Jing G, Shalev A. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells. J Biol Chem. 2013;288:23194–23202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3743491</ArticleId>
            <ArticleId IdType="pubmed">23803610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim DH, Perdomo G, Zhang T, Slusher S, Lee S, Phillips BE, Fan Y, Giannoukakis N, Gramignoli R, Strom S, et al.  FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver. Diabetes. 2011;60:2763–2774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3198083</ArticleId>
            <ArticleId IdType="pubmed">21940782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim DH, Zhang T, Lee S, Calabuig-Navarro V, Yamauchi J, Piccirillo A, Fan Y, Uppala R, Goetzman E, Dong HH. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. Endocrinology. 2014;155:1255–1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3959596</ArticleId>
            <ArticleId IdType="pubmed">24437489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, Accili D. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005;2:153–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16154098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleindorp R, Flachsbart F, Puca AA, Malovini A, Schreiber S, Nebel A. Candidate gene study of FOXO1, FOXO4, and FOXO6 reveals no association with human longevity in Germans. Aging Cell. 2011;10:622–628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21388494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12239572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SS, Kennedy S, Tolonen AC, Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science. 2003;300:644–647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12690206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, et al.  A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell. 2006;125:987–1001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16751106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Wang WJ, Cao HQ, Lu JH, Wu C, Hu FY, Guo J, Zhao L, Yang F, Zhang YX, et al.  Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum Mol Genet. 2009;18:4897–4904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2790334</ArticleId>
            <ArticleId IdType="pubmed">19793722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418:797–801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12181572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S, Milne J, Meyers DJ, Cole P, Yates J, 3rd, et al.  A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008;456:269–273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2597669</ArticleId>
            <ArticleId IdType="pubmed">18849969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manchekar M, Richardson PE, Forte TM, Datta G, Segrest JP, Dashti N. Apolipoprotein B-containing lipoprotein particle assembly: lipid capacity of the nascent lipoprotein particle. J Biol Chem. 2004;279:39757–39766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15254032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest. 2006;116:2464–2472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1533874</ArticleId>
            <ArticleId IdType="pubmed">16906224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 2007;6:208–216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17767907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuzaki H, Daitoku H, Hatta M, Tanaka K, Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci U S A. 2003;100:11285–11290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC208749</ArticleId>
            <ArticleId IdType="pubmed">13679577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Min KJ, Yamamoto R, Buch S, Pankratz M, Tatar M. Drosophila lifespan control by dietary restriction independent of insulin-like signaling. Aging Cell. 2008;7:199–206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2340190</ArticleId>
            <ArticleId IdType="pubmed">18221413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monecke T, Guttler T, Neumann P, Dickmanns A, Gorlich D, Ficner R. Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP. Science. 2009;324:1087–1091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19389996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mueller MM, Castells-Roca L, Babu V, Ermolaeva MA, Muller RU, Frommolt P, Williams AB, Greiss S, Schneider JI, Benzing T, et al.  DAF-16/FOXO and EGL-27/GATA promote developmental growth in response to persistent somatic DNA damage. Nat Cell Biol. 2014;16:1168–1179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4250074</ArticleId>
            <ArticleId IdType="pubmed">25419847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller YL, Hanson RL, Wiessner G, Nieboer L, Kobes S, Piaggi P, Abdussamad M, Okani C, Knowler WC, Bogardus C, et al.  Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians. Obesity (Silver Spring) 2015;23:1960–1965.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4586407</ArticleId>
            <ArticleId IdType="pubmed">26337673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277–283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12845331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mussig K, Staiger H, Machicao F, Stancakova A, Kuusisto J, Laakso M, Thamer C, Machann J, Schick F, Claussen CD, et al.  Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes. J Clin Endocrinol Metab. 2009;94:1353–1360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19141580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J, Joyner AH, Schork NJ, Hsueh WC, Reiner AP, et al.  Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009;8:460–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3652804</ArticleId>
            <ArticleId IdType="pubmed">19489743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, et al.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160:745–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4498261</ArticleId>
            <ArticleId IdType="pubmed">25662011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prager R, Wallace P, Olefsky JM. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 1987;36:607–611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3552793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu S, Altomonte J, Perdomo G, He J, Fan Y, Kamagate A, Meseck M, Dong HH. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology. 2006;147:5641–5652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2665253</ArticleId>
            <ArticleId IdType="pubmed">16997836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salih DA, Rashid AJ, Colas D, de la Torre-Ubieta L, Zhu RP, Morgan AA, Santo EE, Ucar D, Devarajan K, Cole CJ, et al.  FoxO6 regulates memory consolidation and synaptic function. Genes Dev. 2012;26:2780–2801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3533081</ArticleId>
            <ArticleId IdType="pubmed">23222102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci U S A. 2009;106:12121–12126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2707270</ArticleId>
            <ArticleId IdType="pubmed">19587243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimokawa I, Komatsu T, Hayashi N, Kim SE, Kawata T, Park S, Hayashi H, Yamaza H, Chiba T, Mori R. The life-extending effect of dietary restriction requires Foxo3 in mice. Aging Cell. 2015;14:707–709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4531086</ArticleId>
            <ArticleId IdType="pubmed">25808402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soerensen M, Dato S, Christensen K, McGue M, Stevnsner T, Bohr VA, Christiansen L. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell. 2010;9:1010–1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2992870</ArticleId>
            <ArticleId IdType="pubmed">20849522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparks DJ, Dong HH. FoxO1 and hepatic lipid metabolism. Current Opinion in Lipidology. 2009;20:217–226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964835</ArticleId>
            <ArticleId IdType="pubmed">21037971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32:2104–2112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22796579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swift LL, Jovanovska A, Kakkad B, Ong DE. Microsomal triglyceride transfer protein expression in mouse intestine. Histochem Cell Biol. 2005;123:475–482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15891896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swift LL, Zhu MY, Kakkad B, Jovanovska A, Neely MD, Valyi-Nagy K, Roberts RL, Ong DE, Jerome WG. Subcellular localization of microsomal triglyceride transfer protein. J Lipid Res. 2003;44:1841–1849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12837846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tatar M. Comment on “Long-lived Drosophila with overexpressed dFOXO in adult fat body”. Science. 2005;307:675. author reply 675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15692034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Titchenell PM, Chu Q, Monks BR, Birnbaum MJ. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nat Commun. 2015;6:7078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4429930</ArticleId>
            <ArticleId IdType="pubmed">25963408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai WC, Bhattacharyya N, Han LY, Hanover JA, Rechler MM. Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion. Endocrinology. 2003;144:5615–5622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14500580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unger RH, Dobbs RE, Orci L. Insulin, glucagon, and somatostatin secretion in the regulation of metabolism. Annu Rev Physiol. 1978;40:307–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">205166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wahren J, Ekberg K. Splanchnic regulation of glucose production. Annu Rev Nutr. 2007;27:329–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17465853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, Zhang X, Zhao H, Wang Q, Pan Y. FoxO gene family evolution in vertebrates. BMC Evol Biol. 2009;9:222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2746812</ArticleId>
            <ArticleId IdType="pubmed">19732467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B, Curb JD. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A. 2008;105:13987–13992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2544566</ArticleId>
            <ArticleId IdType="pubmed">18765803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, et al.  Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10412986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zemva J, Schilbach K, Stohr O, Moll L, Franko A, Krone W, Wiesner RJ, Schubert M. Central FoxO3a and FoxO6 Expression is Down-regulated in Obesity Induced Diabetes but not in Aging. Exp Clin Endocrinol Diabetes. 2012;120:340–350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22187289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, Kim DH, Xiao X, Lee S, Gong Z, Muzumdar R, Calabuig-Navarro V, Yamauchi J, Harashima H, Wang R, et al.  FoxO1 Plays an Important Role in Regulating beta-Cell Compensation for Insulin Resistance in Male Mice. Endocrinology. 2016;157:1055–1070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4769368</ArticleId>
            <ArticleId IdType="pubmed">26727107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, Wang D, Feng J, Yu L, Zhu WG. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol. 2010;12:665–675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20543840</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
